头孢曲松/舒巴坦对产CTX-M-15型超广谱β-内酰胺酶大肠埃希菌分离株的体外疗效 - Suppr

Suppr

超能文献

In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.

作者信息

Shahid M, Singhai M, Malik A, Shukla I, Khan H M, Shujatullah F, Tahira F

出版信息

J Antimicrob Chemother. 2007 Jul;60(1):187-8. doi: 10.1093/jac/dkm131. Epub 2007 May 8.

DOI:10.1093/jac/dkm131

PMID:17491002

Abstract

摘要

相似文献

In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.

J Antimicrob Chemother. 2007 Jul;60(1):187-8. doi: 10.1093/jac/dkm131. Epub 2007 May 8.

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.

J Chemother. 1989 Jul;1(4 Suppl):273-5.

Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.

Int J Antimicrob Agents. 2008 Oct;32(4):333-8. doi: 10.1016/j.ijantimicag.2008.04.023. Epub 2008 Aug 12.

In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.

New Microbiol. 2009 Jan;32(1):49-55.

Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.

J Basic Microbiol. 2007 Oct;47(5):413-6. doi: 10.1002/jobm.200710318.

Detection of bacterial strains producing sulbactam- or tazobactam-sensitive beta-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibiotics.

APMIS. 2006 Jan;114(1):3-9. doi: 10.1111/j.1600-0463.2006.apm_242.x.

Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.

Braz J Infect Dis. 2000 Feb;4(1):22-8.

In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa.

J Antimicrob Chemother. 2009 Nov;64(5):1115-6. doi: 10.1093/jac/dkp333. Epub 2009 Sep 10.

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Antimicrob Agents Chemother. 2001 Dec;45(12):3548-54. doi: 10.1128/AAC.45.12.3548-3554.2001.

In vitro activity of ceftriaxone plus tazobactam against members of Enterobacteriaceae.

J Assoc Physicians India. 2005 Jul;53:595-8.

引用本文的文献

Bacteriological profile and antibiotic susceptibility of diabetic Foot infections at Ribat University hospital; a retrospective study from Sudan.

J Diabetes Metab Disord. 2020 Oct 13;19(2):1397-1406. doi: 10.1007/s40200-020-00660-8. eCollection 2020 Dec.

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.

Ann Clin Microbiol Antimicrob. 2013 Dec 9;12:38. doi: 10.1186/1476-0711-12-38.

Bacteriological and resistance profile in isolates from diabetic patients.

N Am J Med Sci. 2012 Nov;4(11):563-8. doi: 10.4103/1947-2714.103315.

Citrobacter spp. simultaneously harboring blaCTX-M, blaTEM, blaSHV, blaampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance.

J Clin Microbiol. 2010 May;48(5):1833-8. doi: 10.1128/JCM.01467-09. Epub 2010 Mar 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验